The molecular mechanisms underlying CLDN1-mediated cancer chemoresistance are diverse and include its interaction with EPHA2 kinase, which promotes stemness [31], the upregulation of Unc-51-like autophagy activating kinase 1 (ULK1) phosphorylation [29], and significant alterations in metabolic pathways [42]. Here, ULK1 is linked to cancer.